Akums Drugs and Pharmaceutical (AKUMS) — Capital Reinvestment Ratio
Akums Drugs and Pharmaceutical (AKUMS) has a Capital Reinvestment Ratio of 0.10x as of September 2025, meaning it reinvests 0% of its operating cash flow (Rs11.52 Billion) in capital expenditures (Rs1.12 Billion). Check Akums Drugs and Pharmaceutical (AKUMS) tangible net worth to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Akums Drugs and Pharmaceutical Capital Reinvestment Ratio (2022–2026)
This chart tracks Akums Drugs and Pharmaceutical's Capital Reinvestment Ratio across 5 annual periods. For the full cash flow conversion analysis, see Akums Drugs and Pharmaceutical (AKUMS) cash conversion ratio.
Annual Capital Reinvestment Ratio for Akums Drugs and Pharmaceutical (2022–2026)
Year-by-year Capital Reinvestment Ratio for Akums Drugs and Pharmaceutical from 2022 to 2026. See Akums Drugs and Pharmaceutical free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (INR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2026 | 0.19x | Rs12.11 Billion | Rs2.31 Billion | ▼ -67.5% |
| 2025 | 0.59x | Rs4.65 Billion | Rs2.72 Billion | ▼ -6.3% |
| 2024 | 0.62x | Rs4.98 Billion | Rs3.11 Billion | ▼ -66.4% |
| 2023 | 1.86x | Rs1.77 Billion | Rs3.29 Billion | ▼ -77.0% |
| 2022 | 8.09x | Rs318.54 Million | Rs2.58 Billion | — |